Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~LIVER DONOR:~* Donors older than 16 years~* Liver donation grafts due to brain death~* Steatosis confirmed by histological study (between 30% and 60% of macrovesicular steatosis)~LIVER RECIPIENT:~* Adult patients (18 years or older)~* Active liver transplant waiting list candidate~* Able to give informed consent~Exclusion Criteria:~LIVER DONOR:~* Living donors~* Liver destined to the transplant split~* Donor age \<16 years~* Donation after death due to asystole.~* When the biopsy establishes a steatosis ≥ 50%, patients who fulfill at least 3 of the following 5 risk factors will be excluded: Transaminases (AST and ALT) ≥ 200 U / L; Age ≥ 55 years; Hypernatremia ≥ 155 mEq / L; Cardiovascular risk factors, at least 2 of the following 5: DM, HTA, IMC ≥ 35, Active smoking, ischemic stroke; Days of stay in ICU ≥ 4 days with vasoactive drugs (noradrenaline or dobutamine at any dose)~LIVER RECIPIENT:~* Age under 18~* Acute/fulminant hepatic failure~* Transplant of more than one organ (for example, liver and kidney)~* Rejection of informed consent~* Unable to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Static cold storage (SCS) (Type: EXPERIMENTAL): Traditional method of organ preservation which involves flushing of cold preservation solution following complete dissection and interruption of blood supply to the donor organ. Although cold preservation slows metabolism by 10- to 12-fold, substantial anaerobic activity continues even at ice temperature. This lead to the generation of reactive oxygen species that are the basis of ischaemia-reperfusion injury, when the organ is re-exposed to oxygenated blood at the time of transplantation. This damage, exacerbated by any prior injury, limits the maximum safe preservation time of the donor organ.
- Normothermic machine perfusion (NMP) (Type: EXPERIMENTAL): The main goal of NMP is to optimize graft preservation by mimicking physiological conditions. The perfused organ is supplied with nutrients and oxygen to maintain metabolic hemostasis. Under these conditions, ATP and glycogen reserves can be maintained or actively restored. At the same time, toxic products from the cellular milieu are continuously eliminated, so the cell-mediated injury phase of reperfusion injury can be minimized. Thus, ischemic injury is avoided and the activation of cell death cascades is prevented. This allows both hepatocellular and biliary protection.

Based on this trial design, predict the completion outcome and termination type (if applicable).